As of August 20, 2026, the CDC has confirmed 2,777 measles cases nationwide this year—already exceeding the full 2025 total of 2,289—with 94% linked to ongoing outbreaks across more than 40 jurisdictions and recent weekly additions reaching 211 cases. The virus’s high basic reproduction number (R0 of 12–18) sustains rapid transmission in under-vaccinated communities, particularly among young children, while surveillance relies on confirmed laboratory reports rather than estimates. Traders should monitor the CDC’s next weekly update expected around August 28 and any new state-level outbreak declarations or vaccination campaigns through August 31, as these directly influence final case counts used for market resolution.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado¿Casos de sarampión en EE. UU. antes del 31 de agosto?
¿Casos de sarampión en EE. UU. antes del 31 de agosto?
NUEVO
31 ago 2026
2800+
99%
2825+
93%
2850+
91%
$2,440 Vol.
2800+
$668 Vol.
99%
2825+
$346 Vol.
93%
2850+
$1,426 Vol.
91%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of August 20, 2026, the CDC has confirmed 2,777 measles cases nationwide this year—already exceeding the full 2025 total of 2,289—with 94% linked to ongoing outbreaks across more than 40 jurisdictions and recent weekly additions reaching 211 cases. The virus’s high basic reproduction number (R0 of 12–18) sustains rapid transmission in under-vaccinated communities, particularly among young children, while surveillance relies on confirmed laboratory reports rather than estimates. Traders should monitor the CDC’s next weekly update expected around August 28 and any new state-level outbreak declarations or vaccination campaigns through August 31, as these directly influence final case counts used for market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercado abierto: Aug 24, 2026, 10:08 AM ET
Volumen
$2,440Fecha de finalización
31 ago 2026Mercado abierto
Aug 24, 2026, 10:08 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of August 20, 2026, the CDC has confirmed 2,777 measles cases nationwide this year—already exceeding the full 2025 total of 2,289—with 94% linked to ongoing outbreaks across more than 40 jurisdictions and recent weekly additions reaching 211 cases. The virus’s high basic reproduction number (R0 of 12–18) sustains rapid transmission in under-vaccinated communities, particularly among young children, while surveillance relies on confirmed laboratory reports rather than estimates. Traders should monitor the CDC’s next weekly update expected around August 28 and any new state-level outbreak declarations or vaccination campaigns through August 31, as these directly influence final case counts used for market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$2,440Fecha de finalización
31 ago 2026Mercado abierto
Aug 24, 2026, 10:08 AM ETResolver
0x65070BE91...As of August 20, 2026, the CDC has confirmed 2,777 measles cases nationwide this year—already exceeding the full 2025 total of 2,289—with 94% linked to ongoing outbreaks across more than 40 jurisdictions and recent weekly additions reaching 211 cases. The virus’s high basic reproduction number (R0 of 12–18) sustains rapid transmission in under-vaccinated communities, particularly among young children, while surveillance relies on confirmed laboratory reports rather than estimates. Traders should monitor the CDC’s next weekly update expected around August 28 and any new state-level outbreak declarations or vaccination campaigns through August 31, as these directly influence final case counts used for market resolution.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes